Botulinum toxin A(Q - Med/Galderma)

A型肉毒毒素（Q - Med/Galderma）

Report date: 2026/05/21 20:00:22

Base Information

Drug NameBotulinum toxin A(Q - Med/Galderma)
Drug Alias Namebotulinum toxin neuromodulatorRelabotulinumtoxin Anovel liquid formulation botulinum toxin ARelabotulinumtoxinAQM1114-DP
ClassificationNatural product/Extract > Microbial extractBiologics > Protein drugs > Toxin
Mechanisms of ActionSynaptosomal-associated protein 25 inhibitors
TargetsSynaptosomal-associated protein 25
Therapy Area/IndicationsNasolabial fold wrinklesGlabellar lines
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesPuerto Rico +[4] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesQ-Med ABGalderma Sa
China Registration ClassN/A

Develop Information

Active CompaniesGalderma R&D
Inactive CompaniesN/A
Active IndicationsGlabellar lines
Inactive IndicationsNasolabial fold wrinkles

Other Information

ATC CodeN/A
Related LinksN/A